Smart phone-based pain assessment and monitoring application developer PainChek Ltd (ASX: PCK) has entered the Australian Home Care market, establishing an integrated pain management solution with MPS Connect, a leading Australian medication services company.
The companies have collaborated to integrate the PainChek Universal Solution into the soon to be launched MediSphere Medication Management System.
The system combines pain assessment and pain treatment into one novel software system. The goal is to ensure the right medication is delivered, based on accurate pain assessment, for people living at home with home care packages.
This collaboration will bring together the pain medication expertise of MPS Connect (a subsidiary of Sigma Healthcare) and the pain assessment device from PainChek to monitor the effect of the intervention, creating a unique pain treatment and monitoring programme for people living at home.
In the agreement the PainChek Universal App is fully integrated into the MPS Connect MediSphere system to enhance the user experience and health outcomes for residents, nurses and patients. MPS Connect currently services over 800 preferred pharmacy clients and 1400 Residential Aged care facilities.
MPS Connect Head of Healthcare Operations, Renee Watson, said there are over 235,000 Federal Government funded Home Care packages in Australia, the majority of which are managed by Residential Aged Care providers. MPS Connect has a broad range of pharmaceutical supply agreements with aged care facilities and community pharmacies through existing business agreements and its parent company Sigma Healthcare.
“We are delighted to integrate the PainChek solution into MediSphere, creating an integrated pain assessment and medication management solution for our home-based consumers. We are already a major supplier of pain medication in Australia and this collaboration further elevates our offering to that of a total pain management solution.
“Our initial target clients are the home care providers, but we see opportunities to extend the partnership into broader home consumer markets in line with the increasing demand for home care.”
PainChek CEO, Phillip Daffas, said this is a significant milestone in the company’s home care strategy.
“The MPS MediSphereTM solution is innovative and the integration of PainChek into its medication management suite ensures all home consumers can receive best practice pain and medication management. PainChek Universal was developed specifically to ensure we had a pain assessment solution that also meets the needs of the global aged care, home care, hospital and disability markets. This is another example of how we build innovative partnerships to access new high value markets for PainChek.”
The PainChek Universal system is now fully integrated into the MPS MediSphere system and is being distributed under standard PainChek commercial terms by MPS Connect to both Australian home care and aged care clients as of Q1 2022.
Home Care is a large, growing global market and is financially supported by governments worldwide to enable this strategic shift for the elderly.
